These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 29945324)

  • 1. CCL22 and CCR4 Gene Polymorphisms in Myocardial Infarction: Risk Assessment of rs4359426 and rs2228428 in Iranian Population.
    Noori F; Naeimi S; Zibaeenezhad MJ; Gharemirshamlu FR
    Clin Lab; 2018 Jun; 64(6):907-913. PubMed ID: 29945324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR4 C1014T and CCL22 C16A genetic variations in the Iranian patients with colorectal adenocarcinoma.
    Erfani N; Ahrari S; Ahrari I; Hosseini SV
    Iran J Allergy Asthma Immunol; 2014 Dec; 13(6):440-6. PubMed ID: 25148803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL22 16C/a genetic variation is not associated with breast carcinoma in Southern Iranian population.
    Erfani N; Moghaddasi-Sani F; Razmkhah M; Haghshenas MR; Talei A; Ghaderi A
    Iran J Immunol; 2012 Dec; 9(4):226-33. PubMed ID: 23268288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher circulating levels of chemokines CXCL10, CCL20 and CCL22 in patients with ischemic heart disease.
    Safa A; Rashidinejad HR; Khalili M; Dabiri S; Nemati M; Mohammadi MM; Jafarzadeh A
    Cytokine; 2016 Jul; 83():147-157. PubMed ID: 27152707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.
    Jafarzadeh A; Fooladseresht H; Minaee K; Bazrafshani MR; Khosravimashizi A; Nemati M; Mohammadizadeh M; Mohammadi MM; Ghaderi A
    Tumour Biol; 2015 Feb; 36(2):1163-71. PubMed ID: 25722218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants of C-C motif chemokine 22 (CCL22) are associated with susceptibility to atopic dermatitis: case-control studies.
    Hirota T; Saeki H; Tomita K; Tanaka S; Ebe K; Sakashita M; Yamada T; Fujieda S; Miyatake A; Doi S; Enomoto T; Hizawa N; Sakamoto T; Masuko H; Sasaki T; Ebihara T; Amagai M; Esaki H; Takeuchi S; Furue M; Noguchi E; Kamatani N; Nakamura Y; Kubo M; Tamari M
    PLoS One; 2011; 6(11):e26987. PubMed ID: 22125604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the CCL17/CCL22-CCR4 axis in pediatrics with B-cell acute lymphoblastic leukemia before and after a chemotherapy course.
    Motaghi M; Jafarzadeh A; Farsinejad A; Norouzi A; Khorramdelazad H; Farahmandinia Z; Afgar A; Hassanshahia G
    Cytokine; 2024 Oct; 182():156721. PubMed ID: 39106576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MDC/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
    Flytlie HA; Hvid M; Lindgreen E; Kofod-Olsen E; Petersen EL; Jørgensen A; Deleuran M; Vestergaard C; Deleuran B
    Cytokine; 2010 Jan; 49(1):24-9. PubMed ID: 19942450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of TRGV genes and prognosis-related chemokine/receptor gene expressions in T cell lymphoma].
    Luo Q; Jin Z; Chen S; Yang L; Li B; Li W; Li Y; Wu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):362-366. PubMed ID: 28274317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL22-specific Antibodies Reveal That Engagement of Two Distinct Binding Domains on CCL22 Is Required for CCR4-mediated Function.
    Santulli-Marotto S; Wheeler J; Lacy ER; Boakye K; Luongo J; Wu SJ; Ryan M
    Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):373-80. PubMed ID: 26683175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer.
    Erfani N; Nedaei Ahmadi AS; Ghayumi MA; Mojtahedi Z
    Iran J Med Sci; 2014 Jul; 39(4):367-73. PubMed ID: 25031489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells.
    Hieshima K; Nagakubo D; Nakayama T; Shirakawa AK; Jin Z; Yoshie O
    J Immunol; 2008 Jan; 180(2):931-9. PubMed ID: 18178833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.
    Bonecchi R; Locati M; Galliera E; Vulcano M; Sironi M; Fra AM; Gobbi M; Vecchi A; Sozzani S; Haribabu B; Van Damme J; Mantovani A
    J Immunol; 2004 Apr; 172(8):4972-6. PubMed ID: 15067078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma.
    Wang G; Yu D; Tan W; Zhao D; Wu C; Lin D
    Cancer; 2009 Jun; 115(11):2430-7. PubMed ID: 19298002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-Enhanced Expression of CCL22 in Nasopharyngeal Carcinoma is Associated With CCR4
    Li H; Chen X; Zeng W; Zhou W; Zhou Q; Wang Z; Jiang W; Xie B; Sun LQ
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):126-139. PubMed ID: 32428547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population.
    Wang L; Ma YT; Xie X; Yang YN; Fu ZY; Li XM; Liu F; Huang Y; Ma X; Chen BD; Yuan S; Sun MH; Peng X; Wang BZ
    Clin Appl Thromb Hemost; 2012; 18(1):72-8. PubMed ID: 21733941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel genetic associations and gene-gene interactions of chemokine receptor and chemokine genetic polymorphisms in HIV/AIDS.
    Valverde-Villegas JM; de Medeiros RM; de Andrade KP; Jacovas VC; Dos Santos BR; Simon D; de Matos Almeida SE; Chies JAB
    AIDS; 2017 Jun; 31(9):1235-1243. PubMed ID: 28358741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population.
    Kallel A; Sbaï MH; Sediri Y; Abdessalem S; Mourali MS; Feki M; Mechmeche R; Jemaa R; Kaabachi N
    Cytokine; 2013 Dec; 64(3):646-51. PubMed ID: 24095258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences of IL-1b-3953 C>T and MMP-9-1562C >T Gene Variants on Myocardial Infarction Susceptibility in a Subset of the Iranian Population.
    Daraei A; Mansoori Y; Zendebad Z; Tavakkoly-Bazzaz J; Madadizadeh F; Naghizadeh MM; Arghavani A; Mansoori B
    Genet Test Mol Biomarkers; 2017 Jan; 21(1):33-38. PubMed ID: 27824519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
    Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
    Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.